Increased B-cell activating factor (BAFF)/B-lymphocyte stimulator (BLyS) in primary antiphospholipid syndrome is associated with higher adjusted global antiphospholipid syndrome scores.

van den Hoogen, Lucas L; Palla, Giovanni; Bekker, Cornelis P J; Fritsch-Stork, Ruth D E; Radstake, Timothy R D J; van Roon, Joel A G

van den Hoogen, Lucas L; Palla, Giovanni; Bekker, Cornelis P J; Fritsch-Stork, Ruth D E; Radstake, Timothy R D J; van Roon, Joel A G.

Afiliação

van den Hoogen LL; Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Palla G; Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Bekker CPJ; Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Fritsch-Stork RDE; Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Radstake TRDJ; Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
van Roon JAG; Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.

RMD Open ; 4(2): e000693, 2018.

Article em En | MEDLINE | ID: mdl-30018806

Palavras-chave

B cells; antiphospholipid syndrome; cytokines; systemic lupus erythematosus

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: RMD Open Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Holanda País de publicação: Reino Unido

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google